JANICE MCALISTER: Open Payments
NPI 1164566253 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$26,195 in 104 payments from 9 companies in 2025. Trend: 2023 $37,103 · 2024 $19,486 · 2025 $26,195
Speaker / faculty: $14,178Travel & lodging: $6,204Consulting: $2,703Food & beverage: $2,511Honoraria: $600
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 50 | $20,567 |
| Merck Sharp & Dohme LLC | 10 | $4,061 |
| Novartis Pharmaceuticals Corporation | 31 | $646 |
| Chiesi USA, Inc. | 3 | $606 |
| HEARTFLOW, INC. | 1 | $124 |
| Esperion Therapeutics, Inc. | 3 | $79 |
| PFIZER INC. | 3 | $55 |
| Novo Nordisk Inc | 2 | $35 |
| Regeneron Healthcare Solutions, Inc. | 1 | $22 |
Products named: REPATHA, LEQVIO, JUXTAPID, FFRct, NEXLETOL, UPLIZNA, VYNDAQEL, Wegovy.
Industry payments across GA — which companies pay providers there.
